Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 23 June 2009, doi:10.1136/bmj.b2565
Cite this as: BMJ 2009;338:b2565
Adrian ODowd
1 London
| The first 150 words of the full text of this article appear below. |
The United Kingdom may need to rethink its strategy on use of the antiviral drug oseltamivir (Tamiflu) to treat swine flu, a BMA official has said, as the UKs number of cases is rising faster than in most of the rest of the world.
The number of confirmed cases of A/H1N1 infection in the UK rose from 1752 on Thursday 18 June to 2773 on the following Monday (as the BMJ went to press), says the Health Protection Agency. This was the third biggest jump around the world, which now has 52 427 confirmed cases, the World Health Organization reported, including 231 deaths. In Mexico, where the first major outbreak occurred, no new cases were reported over the weekend.
GPs in the UK may now be starting to deal with the problem differently, said Peter Holden, the BMAs lead on pandemic flu and a negotiator for the General Practitioners Committee.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses